Proteon Therapeutics to Present at the Stifel Nicolaus 2014 Healthcare Conference November 18th

November 17, 2014

WALTHAM, Mass., Nov. 17, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, announced today that Company management will present at the Stifel Nicolaus 2014 Healthcare Conference in New York City on Tuesday, November 18, 2014 at 2:25 pm ET.

About Proteon Therapeutics

Proteon Therapeutics Inc. is developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases. The company is headquartered in Waltham, Mass. For additional information, please visit www.proteontherapeutics.com.

CONTACT:
Investor Contact
George Eldridge,
Senior Vice President and Chief Financial Officer
781-890-0102
geldridge@proteontherapeutics.com

Press Contact
Chris Erdman or Lynnea Olivarez,
MacDougall Biomedical Communications
781-235-3060
proteon@macbiocom.com

IR Tools

  • Printed Materials
  • Email Alerts
  • RSS Feeds
  • Email Page
  • Print

IR Contact

Media Contact

Karen O’Shea, Ph.D.
LifeSci Public Relations
Phone: 929-469-3860
Email: koshea@lifescipublicrelations.com

Social icons